Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.045 USD | +0.50% | +2.49% | -15.66% |
May. 09 | Transcript : Oncternal Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Oncternal Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.66% | 26.64M | |
+63.76% | 62.59B | |
-1.38% | 41.18B | |
+44.64% | 40.29B | |
-8.29% | 27.9B | |
+12.67% | 26.21B | |
-21.63% | 19.09B | |
+5.44% | 13.08B | |
+25.54% | 12.26B | |
+28.41% | 12.05B |
- Stock Market
- Equities
- ONCT Stock
- News Oncternal Therapeutics, Inc.
- Oncternal Therapeutics Says One Patient Dies in Dose Expansion Phase 1/2 Trial of ONCT-808 for B-cell Lymphoma; Shares Fall